High Frequencies of De Novo CNVs in Bipolar Disorder and Schizophrenia-Reference-Cited by-同舟云学术

High Frequencies of De Novo CNVs in Bipolar Disorder and Schizophrenia

Published:2011-12 Issue:6 Volume:72 Page:951-963
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Malhotra Dheeraj,McCarthy Shane,Michaelson Jacob J.,Vacic Vladimir,Burdick Katherine E.,Yoon Seungtai,Cichon Sven,Corvin Aiden,Gary Sydney,Gershon Elliot S.,Gill Michael,Karayiorgou Maria,Kelsoe John R.,Krastoshevsky Olga,Krause Verena,Leibenluft Ellen,Levy Deborah L.,Makarov Vladimir,Bhandari Abhishek,Malhotra Anil K.,McMahon Francis J.,Nöthen Markus M.,Potash James B.,Rietschel Marcella,Schulze Thomas G.,Sebat Jonathan

Publisher

Elsevier BV

Subject

General Neuroscience

Reference39 articles.

1. The genetics of bipolar disorder;Barnett;Neuroscience,2009

2. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement;Baum;Mol. Psychiatry,2008

3. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder;Clayton-Smith;Clin. Dysmorphol.,2010

4. Origins and functional impact of copy number variation in the human genome;Conrad;Nature,2010

5. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder;Ferreira;Nat. Genet.,2008

Cited by 278 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function;Molecular Psychiatry;2024-08-30

2. Progress and Implications from Genetic Studies of Bipolar Disorder;Neuroscience Bulletin;2024-01-11

3. Pleiotropic functions of TAO kinases and their dysregulation in neurological disorders;Science Signaling;2024-01-02

4. Neurobiology of Mood Disorders;Tasman’s Psychiatry;2024

5. Applications of molecular pharmacology in drug discovery;Biochemical and Molecular Pharmacology in Drug Discovery;2024